Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99 | 111 | 104 | 96 | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 | |
| COGS | 46 | 56 | 53 | 40 | 66 | 65 | 51 | 63 | 60 | 65 | 59 | 58 |
| Gross profit | 53 | 55 | 51 | 55 | 59 | 75 | 77 | 65 | 50 | 52 | 63 | 64 |
| 32 | 33 | 34 | 34 | 42 | 41 | 49 | 41 | 43 | 46 | 46 | 47 | |
| 21 | 23 | 16 | 21 | 17 | 33 | 29 | 24 | 8 | 6 | 16 | 17 | |
| OPM % | 21.6% | 20.4% | 15.7% | 22% | 13.8% | 23.8% | 22.3% | 18.8% | 6.8% | 4.9% | 13.5% | 13.6% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 5 | 5 | 5 | 4 | 4 | 5 | 4 |
| Interest | 2 | 2 | 3 | 3 | 2 | 4 | 3 | 3 | 3 | 3 | 4 | 3 |
| 1 | 2 | 7 | 2 | 15 | 2 | 2 | -117 | 7 | -0 | 0 | 1 | |
| Profit before tax | 18 | 20 | 17 | 16 | 27 | 27 | 23 | -101 | 7 | -2 | 8 | 10 |
| Tax | 3 | 4 | 2 | 4 | 6 | 6 | 7 | -0 | -3 | -2 | 0 | 2 |
| Tax % | 17% | 18% | 11.9% | 22.2% | 20.8% | 23.2% | 28.7% | -0% | -41.7% | -99.5% | 0.8% | 19.3% |
| 15 | 16 | 15 | 13 | 21 | 21 | 16 | -101 | 11 | -0 | 8 | 8 | |
| PAT margin % | 15.3% | 14.5% | 14.6% | 13.3% | 16.8% | 14.7% | 12.6% | -78.7% | 9.5% | -0% | 6.3% | 6.7% |
| EPS (₹) | 4.9 | 0.5 | 0.5 | 0.4 | 0.7 | 0.7 | 0.4 | -2.6 | 0.3 | 0 | 0.2 | 0.2 |
| Results filing | — | — | — | — | — | — | Results filing for Mar 2025 | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | — |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +20.3% | +61.1% | +43.8% | +13% | +25.9% | +25.7% | +23.1% | +34% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Pharmaceuticals | 108.21 | 10.82 | 0 | 0 |
| Operational and Management | 13.06 | 2.29 | 0 | 0 |
₹ crore by quarter
| -11.5% |
| -15.9% |
| -4.9% |
| -5.4% |
| PAT YoY % | +11.3% | +64.1% | +107.2% | +17.3% | +39% | +27.3% | +6.6% | -891.3% | -49.9% | -100.1% | -52.7% | — |